Summary of Significant Accounting Policies (Details Textual) (USD $)
|
3 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2014
|
Mar. 31, 2013
|
Dec. 31, 2013
|
Mar. 31, 2014
Sales [Member]
|
Mar. 31, 2013
Sales [Member]
|
Mar. 31, 2014
Sales [Member]
U.S. Department of Energy’s Advanced Research Projects Agency-Energy [Member]
|
Mar. 31, 2013
Sales [Member]
U.S. Department of Energy’s Advanced Research Projects Agency-Energy [Member]
|
Mar. 31, 2014
Accounts Receivable [Member]
|
Mar. 31, 2014
Accounts Receivable [Member]
U.S. Department of Energy’s Advanced Research Projects Agency-Energy [Member]
|
Dec. 31, 2013
Accounts Receivable [Member]
U.S. Department of Energy’s Advanced Research Projects Agency-Energy [Member]
|
Mar. 31, 2014
Patents [Member]
|
|
Summary Of Significant Accounting Policies [Line Items] | |||||||||||
Property, Plant and Equipment, Depreciation Methods | straight-line method | ||||||||||
Finite-Lived Intangible Assets, Amortization Method | straight-line method | ||||||||||
Finite-Lived Intangible Asset, Useful Life | 20 years | ||||||||||
Revenue from Grants | $ 182,595 | $ 222,238 | |||||||||
Grants Receivable, Current | 220,907 | 211,063 | |||||||||
Research And Development Expense Including Grants | 509,376 | 467,681 | |||||||||
Research and Development Expense, Grants | 202,883 | 233,331 | |||||||||
Cash, FDIC Insured Amount | $ 250,000 | ||||||||||
Concentration Risk, Percentage | 33.00% | 24.00% | 63.00% | 58.00% | 28.00% | 65.00% | 84.00% | ||||
Stockholders Equity, Reverse Stock Split | 1-for-2.381 reverse stock split |